Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 244
- Companies
VIVO Cannabis announces findings from clinical study on anxiety and depression
The study provides evidence to support the effectiveness of medical cannabis as a treatment for anxiety and depression.
- Press releases
3rd International Portugal Medical Cannabis Conference (PTMC) To Take Place In Lisbon Next Week
CANNABIS helps children with Autism, Cancer, Epilepsy or even Psychosis and doctors will explain how next week in Lisbon, Portugal.
- Companies
Lyphe Group launches new medical cannabis clinic in Guernsey
The organisation is aiming to support the expanding patient community with the clinic’s opening.
- Medical
Kanabo Posts £4.6m Loss For 2021 But Remains Bullish As It Shifts Focus Towards Dispensing & Prescribing
KANABO has released its first full-year financial results since becoming the second cannabis company in history to launch on the London Stock Exchange (LSE) in February last year.
- Cannabis Daily News
LP’s ‘bleeding cash’ while awaiting legalization
MSO > LPs Large US MSOs are trading at higher revenue multiples than Canadian LPs: Viridian Finally, after trending downward for the last year, American MSOs are trading at higher revenue multiples than Canadian LPs, per Viridian Capital’s latest chart of the week.
- Medical
Tetra Bio-Pharma expands into Australia with new research subsidiary
The Canadian company is establishing research company Tetra Bio-Pharma Australia Pty Ltd.
- Cultivation
Trichome Pharma receives approval to cultivate cannabis for research
The Spanish pharmaceutical company has said the approval marks a significant milestone for the advancement of its pipeline of projects.
- Medical
Phase II trial for potential cannabis dementia treatment completed
MGC Pharma has carried out a clinical trial with its Cognican formula – an oral spray containing THC and CBD.
- Press releases
MGC Pharmaceuticals Releases CogniCann Phase II Clinical Trial Results
MGC Pharmaceuticals Ltd (‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development of phytomedicines, is pleased to provide details of the results of its Phase II Clinical Trial into the effect of its proprietary Investigational Medicinal Product, CogniCann, an oral spray containing delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), on patients…
- Adult-Use
New York’s adult use market estimated to create 60,000 jobs
MOVING TO NY The Green Rush in New York has begun To illustrate the rush to snag one of 60,000 jobs estimated to be created by legalization in the state of New York, the NYT magazine profiled a couple from Tampa, Florida who moved to Brooklyn to try grow their legacy edibles and cannabis business.
- Data & Analysis
A look at Canada’s latest retail cannabis sales data
The CCSI was assessed at C$5.11 per gram this week, up from last week’s C$5.09 per gram.
- Press releases
Avida Labs Appointed By Dermactiva To Produce And Manufacture Its New Skin And Cosmetics Range
HEALTHCARE Branding Ltd has appointed Avida Labs, Europe’s leading CBD manufacturing business, to produce its new soon to be launched skin and body care range under the Dermactiva Brand.












